NCRR Launches National Gene Vector Biorepository

JUNE 19, 2008 — The National Center for Research Resources is replacing its gene vector laboratories program with a national gene vector biorepository and coordinating center, with a three-year, $3 million grant to Indiana University.

Researchers use gene vectors, such as disabled viruses, to carry genetic materials into human tissues in the hope of treating or preventing disease or relieving symptoms. Gene transfer techniques are used in a wide range of studies; examples include those for cancer, heart disease, cystic fibrosis, and immune disorders.

The new biorepository will serve as a central storehouse for gene therapy materials used by academic researchers in preclinical studies. At the same time, the coordinating center will facilitate information-sharing among researchers to promote discoveries, patient safety, and compliance with regulations of the Food and Drug Administration. The center also will broker material transfer agreements between researchers and the owners of patent-protected or proprietary reagents.

The center's databases and educational resources are open to everyone. Other services are limited to gene therapy investigators working in academic or other non-profit organizations.

For more information about NCRR's support for the National Gene Vector Biorepository and Coordinating Center visit www.ncrr.nih.gov/ngvbcc.

Researchers and others interested in this research area can access the services of the biorepository at www.ngvbcc.org.